Kainos Capital amasses over $1bn for third fund

• The fund can commit in excess of $300 million of equity in any single transaction
• Fund III’s investments include CellCore Biosciences, a wellness company; and Specialty Sales, a specialty dairy cow health distribution business
• Kainos Capital backs the middle market

Kainos Capital has closed its third fund at over $1 billion.

Kainos Capital Partners III LP will target businesses in the food and consumer products sectors with at least $10 million in EBITDA.

The fund can commit in excess of $300 million of equity in any single transaction.

On the fundraising, Andrew Rosen, managing partner of Kainos, said in a statement, “Our bench of seasoned investors and operators within the food and consumer sectors helps drive financial and operational performance by working hand-in-glove with management teams. We believe Kainos’ sector experience, industry relationships, and robust operating capabilities make us an attractive partner to families and entrepreneurs who are excited about their business’ prospects yet seek to diversify their wealth.”

Fund III’s investments include CellCore Biosciences, a wellness company; and Specialty Sales, a specialty dairy cow health distribution business.

Kainos Capital backs the middle market.